Cantor Fitzgerald restated their overweight rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report released on Friday, Benzinga reports. The firm currently has a $50.00 target price on the stock. Several other research analysts have also recently issued reports on the company. Wells Fargo & Company increased their price objective on […]
Cabaletta Bio (CABA) – Analysts' Recent Ratings Changes themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cabaletta Bio (NASDAQ:CABA – Free Report) had its price objective boosted by Citigroup from $26.00 to $30.00 in a research report report published on Thursday, Benzinga reports. Citigroup currently has a buy rating on the stock. CABA has been the subject of a number of other research reports. Wells Fargo & Company lifted their target […]
Cabaletta Bio (NASDAQ:CABA) Receives "Overweight" Rating from Cantor Fitzgerald themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Price Target at $33.44 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.